Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Confusion surrounds the availability of compounded semaglutide following regulatory discussions and market shifts in 2024. PlexusDx partners with licensed 503A compounding pharmacies to deliver personalized semaglutide therapy across all 50 states, with injectable options starting at $149 per month and no insurance requirement.
What Happened to Compounded Semaglutide Supply
Regulatory scrutiny of compounded GLP-1 medications intensified throughout 2024, creating uncertainty about ongoing availability. The FDA emphasized that compounded versions are not FDA-approved drugs, yet acknowledged that licensed 503A compounding pharmacies operate within legal frameworks when manufacturing under proper conditions. This distinction matters: unlicensed or 503B facilities operate under different rules, while 503A compounders follow stringent pharmaceutical standards.
Media coverage sometimes conflated different regulatory categories, leading patients to believe all compounded semaglutide became unavailable. In reality, licensed 503A compounding pharmacies continue dispensing semaglutide under state pharmacy board oversight and federal guidelines. PlexusDx works exclusively with these licensed facilities to ensure medication quality and patient safety.
How Licensed 503A Compounding Pharmacies Differ
Licensed 503A compounding pharmacies operate under state-by-state pharmacy board regulation and must adhere to United States Pharmacopeia (USP) standards for sterile preparation. These facilities compound medications on smaller scales, often for individual patients or specific physician orders, rather than manufacturing bulk quantities for mass distribution. PlexusDx sources exclusively from 503A licensed compounders that maintain full compliance with these requirements.
The distinction from 503B outsourcing facilities is critical: 503B entities operate under different federal oversight and manufacture larger batches, sometimes without a specific patient prescription. Licensed 503A compounding pharmacies cannot legally provide the same large-scale distribution model that 503B facilities use. This regulatory separation exists to protect patient safety and ensure medication quality at the point of dispensing.
Compounded Semaglutide Availability Through PlexusDx
PlexusDx offers compounded semaglutide injections starting at $149 per month through its network of licensed 503A compounding pharmacies. This pricing remains flat regardless of your dose level—meaning if your clinician increases your dose, your monthly cost stays the same. The service includes access to all 50 states, no insurance requirement, and HSA or FSA eligibility for those with qualifying accounts.
The ordering process begins with a brief medical consultation conducted by PlexusDx clinicians who review your health history, current medications, and weight loss goals. Once cleared, your compounded semaglutide is prepared at a licensed pharmacy and shipped directly to your home with temperature-controlled packaging. PlexusDx does not charge membership fees or require insurance preapproval, making the pathway to treatment more direct than traditional pharmacy routes.
Personalization Through Genetic Testing
Not all patients respond equally to semaglutide due to differences in genetic pathways that influence GLP-1 receptor function and weight regulation. PlexusDx offers the Precision Peptide Genetic Test as an optional add-on for $99 after your first month of treatment. This test analyzes your unique genetic variants across 14 metabolic pathways, including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—insights that guide whether semaglutide, tirzepatide, or dual-compound therapy may be most effective for your body.
Understanding your peptide pathway genetics allows PlexusDx clinicians to recommend the therapy most likely to deliver results for your specific biology. Some patients achieve better outcomes with tirzepatide's dual GIP and GLP-1 action, while others respond powerfully to semaglutide alone. Genetic data removes guesswork from medication selection, helping you avoid months of trial-and-error that waste time and money.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide still legal to prescribe and use?
Yes. Licensed 503A compounding pharmacies continue operating legally under state and federal oversight. While compounded semaglutide is not FDA-approved, its manufacture and distribution through licensed 503A facilities remain permissible. PlexusDx ensures all medications come from compliant licensed pharmacies.
How does PlexusDx semaglutide differ from brand-name Ozempic?
PlexusDx semaglutide is compounded from pharmaceutical-grade ingredients by licensed 503A pharmacies, whereas Ozempic is FDA-approved and manufactured by Novo Nordisk. Both contain the same active ingredient (semaglutide), but compounded versions cost significantly less and require no insurance.
What if my dose needs to increase—will my price go up?
No. PlexusDx pricing is flat per compound and does not change with dose adjustments. Your compounded semaglutide injection remains $149 per month whether your clinician prescribes 0.5 mg or 2.4 mg weekly. The pricing philosophy is: your dose may need to go up, but your price won't.
Can I use my HSA or FSA to pay for PlexusDx semaglutide?
Yes. PlexusDx compounded medications are HSA and FSA eligible, allowing you to use pre-tax healthcare dollars to reduce your out-of-pocket cost. This tax advantage can lower your effective monthly price even further below the $149 starting rate.
How does the Precision Peptide Genetic Test help determine if semaglutide is right for me?
The Precision Peptide Genetic Test ($99 add-on) analyzes 150+ genetic insights across four key weight-regulation variants: GIPR, GLP1R, FTO, and MC4R.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Ozempic Shots Hurt? What to Expect and How to Stay Comfortable
Is Semaglutide Pill or Injection Better for Weight Loss?